financetom
Business
financetom
/
Business
/
Bill Hwang's trial begins over collapse of his $36 billion Archegos fund
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Bill Hwang's trial begins over collapse of his $36 billion Archegos fund
May 8, 2024 3:59 AM

NEW YORK (Reuters) - Sung Kook "Bill" Hwang's criminal racketeering trial over the collapse of Archegos Capital Management begins on Wednesday with the selection of jurors who will decide if he and a deputy broke the law in a massive stock scheme that unraveled in just days in 2021.

The trial in Manhattan federal court is expected to last up to eight weeks and will delve into the implosion of Hwang's lightly regulated family investment office, which prosecutors allege caused more than $100 billion in shareholder losses at companies in its portfolio.

Federal prosecutors accuse Hwang of using derivatives to secretly amass positions in multiple stocks that were so large they eclipsed that of the companies' largest investors, driving up stock prices.

They also claim Hwang and former Archegos Chief Financial Officer Patrick Halligan then lied about their holdings to sustain their business relationship with global banks.

Hwang and Halligan are charged with racketeering conspiracy. Hwang faces an additional 10 counts of fraud and market manipulation, and Halligan an additional two counts of fraud.

The two men have pleaded not guilty and are expected to argue prosecutors are pushing a novel and nonsensical market manipulation theory. Several attorneys told Reuters it may be a tough case for prosecutors.

Hwang's lawyers have described the case as the "most aggressive open market manipulation case ever" brought by prosecutors.

Each count carries a maximum potential sentence of 20 years.

Archegos head trader William Tomita and Chief Risk Officer Scott Becker have pleaded guilty to related charges and are expected to testify at the trial.

The trial will begin with jury selection on Wednesday and Thursday and opening statements on Monday. The judge has said there are unlikely to be proceedings on Fridays.

Wednesday will focus on identifying potential jurors who can serve the length of the trial and on Thursday the judge and legal teams will determine the suitability and impartiality of potential jurors. There will be 12 jurors and four alternates.

Archegos' March 2021 collapse stemmed from Hwang's use of financial contracts known as total return swaps to take outsized stakes in his favorite holdings without actually owning the stock.

Authorities have said Archegos borrowed aggressively to boost trading capacity and at its peak had $36 billion in assets and $160 billion of exposure to equities. Falling stock prices in March 2021 triggered margin calls that Archegos was unable to meet.

That led some banks to dump stocks backing his swaps, causing big losses for Archegos and its lenders, such as Credit Suisse, now part of UBS, and Nomura Holdings.

U.S. District Judge Alvin Hellerstein, who is overseeing the trial, rejected Hwang and Halligan's motion to dismiss the case last year.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Palisades Goldcorp Reports Renewal of Normal Course Issuer Bid
Palisades Goldcorp Reports Renewal of Normal Course Issuer Bid
Mar 26, 2024
01:46 PM EDT, 03/26/2024 (MT Newswires) -- Palisades Goldcorp Ltd. ( PLGDF ) on Tuesday rose 2.2% on last look after reporting that it has secured approval from the TSX Venture Exchange for the company's plan to renew its normal course issuer bid for common shares through the facilities of the TSX-V. Effective April 1, the renewal allows the company...
UK's DS Smith in deal talks with International Paper
UK's DS Smith in deal talks with International Paper
Mar 26, 2024
March 26 (Reuters) - Paper and packaging company DS Smith ( DITHF ) said on Tuesday that it is in discussions with U.S.-listed International Paper ( IP ) regarding a proposal to buy the British packaging firm through a possible all-share offer. Under the terms of the proposal, DS Smith ( DITHF ) shareholders would receive 0.1285 shares in International...
Spotify Technology Unusual Options Activity
Spotify Technology Unusual Options Activity
Mar 26, 2024
Investors with a lot of money to spend have taken a bullish stance on Spotify Technology ( SPOT ) . And retail traders should know. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know. But when something this...
Obesity Drug Landscape Has A Contender From Biohaven, CEO Highlights Different Approach Amid Stiff Competition From Novo Nordisk, Eli Lilly
Obesity Drug Landscape Has A Contender From Biohaven, CEO Highlights Different Approach Amid Stiff Competition From Novo Nordisk, Eli Lilly
Mar 26, 2024
Monday, Biohaven’s CEO, Vlad Coric, joined CNBC Fast Money to discuss the weight loss drug wars and the company’s experimental obesity drug. Biohaven ( BHVN ) said it is developing an obesity drug that works differently from Novo Nordisk A/S’s and Eli Lilly And Co’s popular GLP-1 drugs. The experimental obesity drug, dubbed taldefgrobep alfa (BHVN-2000), could prevent muscle loss while helping shed weight. The company highlights that 20%-50%...
Copyright 2023-2026 - www.financetom.com All Rights Reserved